A case report of synchronous multiple primary cancers: mediastinal ganglioneuroblastoma with left adrenocortical carcinoma in a child

References:

[1] Zhai CY,Cai YL,Lou F,et al.Multiple primary malignant tumors-A clinical analysis of 15,321 patients with malignancies at a single center in China[J].J Cancer,2018,9(16):2795-2801.DOI:10.7150/jca.25482.
[2] Alhamadh MS,Alanazi RB,Algarni ST,et al.A descriptive study of the types and survival patterns of Saudi patients with multiple primary solid malignancies:a 30-year tertiary care center experience[J].Curr Oncol,2022,29(7):4941-4955.DOI:10.3390/curroncol29070393.
[3] 王鑫,俞凯杰,詹镇润,等.同时性三重原发癌合并胃间质瘤1例[J].肿瘤预防与治疗,2023,36(7):611-615.DOI:10.3969/j.issn.1674-0904.2023.07.011. Wang X,Yu KJ,Zhan ZR,et al.Simultaneous triple primary malignancies plus gastric stromal tumor:one case report[J].J Cancer Control Treat,2023,36(7):611-615.DOI:10.3969/j.issn.1674-0904.2023.07.011.
[4] Li R,Polishchuk A,DuBois S,et al.Patterns of relapse in high-risk neuroblastoma patients treated with and without total body irradiation[J].Int J Radiat Oncol Biol Phys,2017,97(2):270-277.DOI:10.1016/j.ijrobp.2016.10.047.
[5] Zeineldin M,Patel AG,Dyer MA.Neuroblastoma:when differentiation goes awry[J].Neuron,2022,110(18):2916-2928.DOI:10.1016/j.neuron.2022.07.012.
[6] 杨瑞雪,王晓琳,王一超,等.结节型节细胞神经母细胞瘤3例并文献复习[J].中国组织化学与细胞化学杂志,2020,29(3):264-267,273.DOI:10.16705/j.cnki.1004-1850.2020.03.011. Yang RX,Wang XL,Wang YC,et al.Nodular ganglioneuroblastoma:a report of 3 cases with a literature review[J].Chin J Histochem Cytochem,2020,29(3):264-267,273.DOI:10.16705/j.cnki.1004-1850.2020.03.011.
[7] 中国医师协会泌尿外科分会.肾上腺皮质癌诊治专家共识[J].现代泌尿外科杂志,2021,26(11):902-908.DOI:10.3969/j.issn.1009-8291.2021.11.002. Branch of Urology,Chinese Medical Doctor Association.Expert Consensus on Diagnosing and Treating Adrenal Cortical Cancer[J].J Mod Urol,2021,26(11):902-908.DOI:10.3969/j.issn.1009-8291.2021.11.002.
[8] Li P,Su XN,Zhang XT,et al.Prognostic factors of adrenocortical carcinoma:experience from a regional medical center in eastern China[J].Int J Gen Med,2023,16:453-465.DOI:10.2147/IJGM.S399473..
[9] Zhang SL,Xiao BL,Zhang YW,et al.Retroperitoneal ganglioneuroblastoma with postoperative stress ulcer perforation in an adolescent:a case report and review of the literature[J].Oncol Lett,2022,24(1):208.DOI:10.3892/ol.2022.13329.
[10] Zhang QY,Zhou TT,Hou PM,et al.A single-center study of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumors[J].Thorac Cancer,2023,14(1):44-51.DOI:10.1111/1759-7714.14708.
[11] Heidari Z,Kaykhaei MA,Jahantigh M,et al.Adrenal ganglioneuroblastoma in an adult:a rare case report[J].Int J Endocrinol Metab,2018,16(1):e63055.DOI:10.5812/ijem.63055.
[12] 王浩入,陈欣,张黎,等.儿童腹膜后结节型和混合型节细胞神经母细胞瘤的临床及CT表现[J].中国临床医学影像杂志,2022,33(4):279-282.DOI:10.12117/jccmi.2022.04.011. Wang HR,Chen X,Zhang L,et al.CT findings and clinical features of retroperitoneal nodular and intermixed ganglioneuroblastoma in children[J].J Chin Clin Med Imaging,2022,33(4):279-282.DOI:10.12117/jccmi.2022.04.011.
[13] He WG,Yan Y,Tang W,et al.Clinical and biological features of neuroblastic tumors:a comparison of neuroblastoma and ganglioneuroblastoma[J].Oncotarget,2017,8(23):37730-37739.DOI:10.18632/oncotarget.17146.
[14] 张琼,任静祎,纪洪辰,等.肾上腺皮质癌1例报道并文献回顾[J].现代肿瘤医学,2021,29(23):4153-4158.DOI:10.3969/j.issn.1672-4992.2021.23.017. Zhang Q,Ren JY,Ji HC,et al.Adrenocortical carcinoma:one case report with a literature review[J].J Mod Oncol,2021,29(23):4153-4158.DOI:10.3969/j.issn.1672-4992.2021.23.017.
[15] Lai GC,Liu H,Deng JL,et al.The characteristics of tumor microenvironment predict survival and response to immunotherapy in adrenocortical carcinomas[J].Cells,2023,12(5):755.DOI:10.3390/cells12050755.
[16] Margonis GA,Kim Y,Prescott JD,et al.Adrenocortical carcinoma:impact of surgical margin status on long-term outcomes[J].Ann Surg Oncol,2016,23(1):134-141.DOI:10.1245/s10434-015-4803-x.
[17] Fassnacht M,Assie G,Baudin E,et al.Adrenocortical carcinomas and malignant phaeochromocytomas:ESMO-EURACAN Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2020,31(11):1476-1490.DOI:10.1016/j.annonc.2020.08.2099.
[18] Hescot S,Debien V,Hadoux J,et al.Outcome of adrenocortical carcinoma patients included in early phase clinical trials:results from the French network ENDOCAN-COMETE[J].Eur J Cancer,2023,189:112917.DOI:10.1016/j.ejca.2023.05.006.
[19] Fassnacht M,Terzolo M,Allolio B,et al.Combination chemotherapy in advanced adrenocortical carcinoma[J].N Engl J Med,2012,366(23):2189-2197.DOI:10.1056/NEJMoa1200966.
[20] Nyqvist J,Kovács A,Einbeigi Z,et al.Genetic alterations associated with multiple primary malignancies[J].Cancer Med,2021,10(13):4465-4477.DOI:10.1002/cam4.3975.
[21] Riedmeier M,Antonini SRR,Brandalise S,et al.International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors:indications,therapy,and management of adverse effects[J].Eur J Endocrinol,2024,190(4):G15-G24.DOI:10.1093/ejendo/lvae038.